The rising global prevalence of inflammatory bowel diseases (IBD), such as Crohn's disease
(CD) and ulcerative colitis (UC), underscores the need to examine current and future IBD …

Significant progress in the management and modification of inflammatory bowel disease
(IBD) has been made; however, significant barriers to the optimization of IBD care in the …

Background: Anesthesia staffing models rely on predictable surgical case volumes. Previous
studies have found no relationship between month of the year and surgical volume …

Background By increasing cost sharing, high‐deductible health plans (HDHPs) aim to
reduce low‐value health care use. The association of HDHPs with health care use and costs …

Background Private insurers use the calendar deductible system, placing pressure on
patients and medical personnel to perform medical services before the end of the year to …

In a value-based care environment, a goal is to favor outpatient surgery to reduce costs.
Unfortunately, while outpatient (as compared to inpatient) surgery reduces overall cost …

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders
worldwide, with a global prevalence of over 10%. 1 Although the per-person costs for …

Background: Insurer-mandated barriers to timely initiation of advanced therapies used to
treat inflammatory bowel disease (IBD) have been shown to worsen clinical outcomes and …

METHODS: We conducted a survey within the IBD Partners longitudinal cohort to evaluate
the frequency and patient-reported impacts of medication utilization barriers on insurance …